Search Results | Blood | American Society of Hematology

1-20 of 55

2 3

Sort by

Sort Order Select

Journal Articles

Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival

Farah Fleti, Amritpal Singh, Aref Al-Kali, James M. Foran, Michelle A Elliott, Kebede Begna, Talha Badar, Nandita Khera, Mithun V. Shah, Hassan B. Alkhateeb, Maymona Abdelmagid, Kaaren K. Reichard, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi

Blood (2022) 140 (Supplement 1): 6940–6941.

DOI: https://doi.org/10.1182/blood-2022-163518

Published: 2022

Journal Articles

A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study

David K. Buchbinder, Neel S. Bhatt, Huiqi Wang, Yutaka Yasui, Saro H. Armenian, Smita Bhatia, Eric J. Chow, I-Chan Huang, Anne C. Kirchhoff, Wendy Leisenring, K. Robin Yabroff, Gregory T. Armstrong, Paul Nathan, Nandita Khera

Blood (2022) 140 (Supplement 1): 10981–10982.

DOI: https://doi.org/10.1182/blood-2022-159132

Published: 2022

Journal Articles

Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome

Animesh Pardanani, Ayalew Tefferi, Amritpal Singh, Aref Al-Kali, Mrinal M. Patnaik, William J. Hogan, Kebede Begna, Michelle A Elliott, Nandita Khera, Jeanne M. Palmer, Naseema Gangat, Attilio Orazi, Katalin Kelemen, Kaaren K. Reichard, Dong Chen

Blood (2022) 140 (Supplement 1): 6872–6873.

DOI: https://doi.org/10.1182/blood-2022-167720

Published: 2022

Journal Articles

A Phase 1b Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Stem Cell Transplantation

Doris M Ponce, Jonathan U Peled, Bindu Tejura, Christopher Ford, Marcel R M van den Brink, Mary Jane Lombardo, Satyajit Kosuri, Nandita Khera, Zachariah Defilipp, Lisa von Moltke

Blood (2022) 140 (Supplement 1): 10532–10533.

DOI: https://doi.org/10.1182/blood-2022-162386

Published: 2022

Journal Articles

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience

Blood (2022) 140 (Supplement 1): 914–916.

DOI: https://doi.org/10.1182/blood-2022-164600

Published: 2022

Journal Articles

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

Blood (2022) 140 (Supplement 1): 8019–8021.

DOI: https://doi.org/10.1182/blood-2022-167411

Published: 2022

Journal Articles

IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort

Razan Mohty, Yenny Moreno Vanegas, Michael G. Heckman, Hassan B. Alkhateeb, Alexander P. Hochwald, William J. Hogan, Mohamed A. Kharfan-Dabaja, Rhett P. Ketterling, Nandita Khera, Mark R. Litzow, Abhishek A. Mangaonkar, Hemant S. Murthy, Jeanne M. Palmer, Mithun V. Shah, Lisa Z. Sproat, David S. Viswanatha, James M. Foran

Blood (2022) 140 (Supplement 1): 4863–4864.

DOI: https://doi.org/10.1182/blood-2022-168053

Published: 2022

Journal Articles

The Sustainability of Price Dynamics in Precision Hematology

Caleb J Scheckel, Aakash Desai, Chelsee Jensen, Jacob Orme, Nandita Khera, Joshua C. Pritchett, Amit Mahipal, Ronald Go

Blood (2021) 138 (Supplement 1): 114.

DOI: https://doi.org/10.1182/blood-2021-152715

Published: 2021

Journal Articles

Financial Hardship Amongst Patients with Hematologic Malignancies: Using the EMR to Streamline and Prioritize Patient-Centered Care

Sandeep S Voleti, Nandita Khera, Carolyn Mead-Harvey, Sikander Ailawadhi, Rafael Fonseca, Joan Griffin, Rahma M Warsame

Blood (2021) 138 (Supplement 1): 661.

DOI: https://doi.org/10.1182/blood-2021-150546

Published: 2021

Journal Articles

Higher Skeletal Muscle Index Is Associated with Improved Overall Survival in Older Patients with Sarcopenia Undergoing Allogeneic Stem Cell Transplant

Charles Gaulin, Blake T. Langlais, Luke Mountjoy, Panagiotis Korfiatis, Nelly Tan, Jose F. Leis, Nandita Khera, Pierre Noel, Lisa Z. Sproat, Tania Jain, Jeanne M. Palmer

Blood (2021) 138 (Supplement 1): 3960.

DOI: https://doi.org/10.1182/blood-2021-149274

Published: 2021

Journal Articles

Trends in Use and Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Racial/Ethnic Minorities

Nandita Khera, Theresa E. Hahn, Ruta Brazauskas, Benjamin Jacobs, Leslie E. Lehmann, Hashmi Shahrukh, William A. Wood, Sikander Ailawadhi, Wael Saber

Blood (2021) 138 (Supplement 1): 427.

DOI: https://doi.org/10.1182/blood-2021-146967

Published: 2021

Journal Articles

Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myeloid Leukemia

Lih-Wen Mau, Jaime M. Preussler, Christa Meyer, Mary Senneka, Sophie Wallerstedt, Patricia Steinert, Nandita Khera, Wael Saber

Blood (2021) 138 (Supplement 1): 4044.

DOI: https://doi.org/10.1182/blood-2021-153196

Published: 2021

Journal Articles

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

Blood (2021) 137 (4): 556–568.

DOI: https://doi.org/10.1182/blood.2020006252

Published: 2021

Includes: Supplemental data

Journal Articles

Prognostic Impact of a Modified European LeukemiaNet (ELN) Genetic Risk Stratification in Predicting Outcomes for Adults with Acute Myeloid Leukemia (AML) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT). a Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis for the CIBMTR Acute Leukemia Writing Committee

Blood (2020) 136 (Supplement 1): 27–29.

DOI: https://doi.org/10.1182/blood-2020-137589

Published: 2020

Journal Articles

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

David K. Buchbinder, MD MSHS, Ruta Brazauskas, PhD, Khalid Bo-Subait, Karen K. Ballen, MD, Theresa E. Hahn, PhD, Tami D John, MD, Susan K Parsons, MD MRP, Shahrukh K. Hashmi, MD MPH, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 2260.

DOI: https://doi.org/10.1182/blood-2018-99-116531

Published: 2018

Journal Articles

Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?

Tania Jain, MD, Luke Mountjoy, DO, Katie L. Kunze, PhD, Pierre Noel, MD, Nandita Khera, MD, Jose F. Leis, MD PhD, James L. Slack, MD, Lisa Z. Sproat, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 3360.

DOI: https://doi.org/10.1182/blood-2018-99-115287

Published: 2018

Journal Articles

Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study

Rohini Radia, MD FRCPath, Arun Alfred, Matthew P. Collin, MD PhD, Maria H Gilleece, MD FRCPath, MB, BSc, FRCP, James E Griffin, BSc (Hons), MBChB (Hons), PhD, Ann E. Hunter, MBBS, FRCP, FRCPath, Hannah Hunter, MB, FRCPath, MRCP, Harpreet Kaur, Nandita Khera, MD, Kavita Raj, MD PhD, Emma Das-Gupta, DM, FRCPath, MRCP, Fiona Louise Dignan, MD, Madan Jagasia, MD MS

Blood (2018) 132 (Supplement 1): 3408.

DOI: https://doi.org/10.1182/blood-2018-99-115376

Published: 2018

Journal Articles

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Kira O Bona, MDMPH, Ruta Brazauskas, PhD, Naya He, Leslie E. Lehmann, MD, Joanne Wolfe, MD MPH, Jignesh Dalal, MD, Shahrukh K. Hashmi, MDMPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Christine Duncan, MD MSc, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 714.

DOI: https://doi.org/10.1182/blood-2018-99-118544

Published: 2018

Journal Articles

Clinical Outcomes of Matched Unrelated Allogeneic Stem Cell Transplant Patients: Low Dose ATG Vs. No ATG

Luke Mountjoy, DO, Katie L. Kunze, PhD, Tania Jain, MD, James L. Slack, MD, Nandita Khera, MD, Jose F. Leis, MD PhD, Pierre Noel, MD, Lisa Z. Sproat, Jeanne Palmer, MD

Blood (2018) 132 (Supplement 1): 5715.

DOI: https://doi.org/10.1182/blood-2018-99-112217

Published: 2018

Journal Articles

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Jason Tay, MD, Ruta Brazauskas, PhD, Naya He, Sara Beattie, Christopher Bredeson, MD FRCPC, MSc, Jignesh Dalal, MD, Shahrukh K. Hashmi, MD MPH, Theresa E. Hahn, PhD, Nandita Khera, MD, William A. Wood, MD MPH, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 4788.

DOI: https://doi.org/10.1182/blood-2018-99-117027

Published: 2018

2 3

NARROW

Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival

A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study

Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome

A Phase 1b Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Stem Cell Transplantation

Outcomes after Transplant in Relapsed/Refractory KMT2Ar (MLLr) and mNPM1 (NPM1c) leukemia Patients Achieving Remissions after Menin Inhibition: SNDX-5613 (revumenib) Ph1 Experience

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

IPSS-Molecular but Not Individual Mutations Predicts Outcomes of Patients with Myelodysplastic Syndrome (MDS) after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT): A Mayo Clinic Cohort

The Sustainability of Price Dynamics in Precision Hematology

Financial Hardship Amongst Patients with Hematologic Malignancies: Using the EMR to Streamline and Prioritize Patient-Centered Care

Higher Skeletal Muscle Index Is Associated with Improved Overall Survival in Older Patients with Sarcopenia Undergoing Allogeneic Stem Cell Transplant

Trends in Use and Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Racial/Ethnic Minorities

Trends in Allogeneic Hematopoietic Cell Transplantation Utilization and Estimated Unmet Need Among Medicare Beneficiaries with Acute Myeloid Leukemia

Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis

Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplant Research

Does Early T Cell Chimerism Predict Outcomes after Allogeneic Hematopoietic Cell Transplantation ?

Prospective Outcomes of Second Line Therapy in Acute Gvhd: Six Month Freedom from Treatment Failure and Day 28 Response in a Multicentre Study

Area-Based Socioeconomic Status and Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Outcomes: A CIBMTR Analysis

Clinical Outcomes of Matched Unrelated Allogeneic Stem Cell Transplant Patients: Low Dose ATG Vs. No ATG

The Impact of Marital Status on Hematopoietic Stem Cell Transplant (HCT) Recipient Outcomes: A Surrogate for Consistent Caregiver. a CIBMTR Registry Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only